Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial
Sarah H. O’Brien, Vilmarie Rodriguez, Glen Lew, Jane W. Newburger, Corinna L. Schultz, Etan Orgel, Kimberly Derr, Mark Ranalli, Adam J. Esbenshade, Jessica Hochberg, Hyoung Jin Kang, Yu. V. Dinikina, Donna Mills, Mark Donovan, Joshua L. Dyme, Nicholas Favatella, Lesley Mitchell
Topics & Concepts
MedicineApixabanPopulationInternal medicineSurgeryPediatricsWarfarinRivaroxabanEnvironmental healthAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsAcute Lymphoblastic Leukemia research